The benefits of avoiding cancer (or dying from cancer): Evidence from a four- country study

Anna Alberini and Milan Ščasný ()

Journal of Health Economics, 2018, vol. 57, issue C, 249-262

Abstract: We use stated-preference methods to estimate the cancer Value per Statistical Life (VSL) and Value per Statistical Case (VSCC) from a representative sample of 45–60-year olds in four countries in Europe. We ask respondents to report information about their willingness to pay for health risk reductions that are different from those used in earlier valuation work because they are comprised of two probabilities—that of getting cancer, and that of dying from it (conditional on getting it in the first place). The product of these two probabilities is the unconditional cancer mortality risk. Our hypothetical risk reductions also include two severity-related attributes—quality-of-life impacts and pain. The results show that respondents did appear to have an intuitive grasp of compound probabilities, and took into account each component of the unconditional cancer mortality risk when answering the valuation questions. We estimate the cancer VSL to be between approximately € 2 and 5.950 million, depending on whether the (unconditional) mortality risk was reduced by lowering the chance of getting cancer, increasing the chance of surviving cancer, or both. The VSCC is estimated to be up to € 0.578 million euro, and its magnitude depends on the initial (conditional) cancer mortality and on the improvement in survival. The survey responses show that our measures of cancer severity—impacts on daily activities and pain—have little or no effect on the WTP to reduce the adverse health risks.

Keywords: Cancer risk; Value of a statistical life; Value of a statistical case of cancer; Mortality risk reduction; Stated preferences (search for similar items in EconPapers)
JEL-codes: I18 J17 K32 Q51 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (8)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167629616305082
Full text for ScienceDirect subscribers only

Related works:
Working Paper: The Benefits of Avoiding Cancer (or Dying from Cancer): Evidence from a Four-country Study (2017)
Working Paper: The Benefits of Avoiding Cancer (or Dying from Cancer): Evidence from a Four-country Study (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:jhecon:v:57:y:2018:i:c:p:249-262

DOI: 10.1016/j.jhealeco.2017.08.004

Access Statistics for this article

Journal of Health Economics is currently edited by J. P. Newhouse, A. J. Culyer, R. Frank, K. Claxton and T. McGuire

More articles in Journal of Health Economics from Elsevier
Bibliographic data for series maintained by Catherine Liu ().